Chester County News and Community Website
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More
WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) released its final guidance for the third cycle of the Medicare Drug Price Negotiation Program on Tuesday, introducing major …
CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections Read More
WASHINGTON, D.C. — The Departments of Labor, Health and Human Services, and the Treasury have announced new measures to advance healthcare price transparency. These actions, initiated on Thursday, May 22, …
Know What You Pay: Bold Federal Push for Real Healthcare Price Transparency Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has announced plans to enforce President Donald J. Trump’s Executive Order on Most-Favored-Nation (MFN) Prescription Drug Pricing. This …
Game-Changer for Drug Prices: HHS Steps in to End Outrageous Costs Read More
WASHINGTON, D.C. — The U.S. Centers for Medicare & Medicaid Services (CMS) has announced the selection of 15 additional drugs for price negotiations under the Medicare Drug Price Negotiation Program. …
Big Win for Patients! Medicare Takes Bold Step to Slash Prescription Drug Prices Read More
WASHINGTON, D.C. — In the final days of the Biden-Harris Administration, the U.S. Department of Health and Human Services (HHS) last week announced 15 additional drugs selected for Medicare Part …
HHS Announces 15 More Drugs for Medicare Price Negotiations in Final Days of Biden-Harris Administration Read More
HARRISBURG, PA — Attorney General Michelle Henry, along with a coalition of 50 states and territories, announced settlements with Heritage Pharmaceuticals and Apotex. These agreements, amounting to $49.1 million, address …
States Secure $49.1 Million Settlement Over Drug Price Manipulation Read More
WASHINGTON, D.C. — The Inflation Reduction Act, a pivotal component of the Biden-Harris Administration’s healthcare strategy, has delivered substantial financial relief to Medicare Part D enrollees. New data released by …
Inflation Reduction Act Yields Significant Savings for Medicare Part D Enrollees Read More
WASHINGTON, D.C. — As the clock ticks down to January 2025, when a crucial element of the Inflation Reduction Act (IRA) takes effect, U.S. Senators Bob Casey (D-PA) and Raphael Warnock …
Senior Savings Alert: Senators Push for Outreach on New Drug Cost Cap Read More
PHILADELPHIA, PA — IntegriChain has announced that its pharmaceutical pricing and regulatory experts will take the stage at the upcoming Medicaid Drug Rebate Reporting Summit 2024, scheduled from September 23 to …
IntegriChain to Present Key Insights at Medicaid Drug Rebate Reporting Summit 2024 Read More